grit42 has given our project team access to enterprise level software tools for data management, archiving and analysis which are uniquely able to work with discovery, clinical and clinical data sets in an interoperable environment.
They are a great company and we are very proud to collaborate with them to try and improve the process of antibiotic drug discovery through the implementation of FAIR data management and tools.
Grit42 is providing the IMI ERA4TB project with innovative, flexible data management solutions that greatly facilitate the handling of the variety of complex drug discovery and development datasets needed to support world-class TB research.
Based on our experience and the ability to organize all data types in a consistent fashion, this platform can be a key tool for any researcher to address key scientific questions within the areas of drug development and translational research activities.
As our research in Nucleic acid-based medicine involves data generation from biological and in silico experiments, both from several different sources, it is of utmost importance that our data consolidation process is streamlined and that the stored data is easily accessible, which is what we get with grit42.
We see a great potential in applying state-of-the-art data management and data integration to leverage our R&D activities and improve our decision making. To strengthen these capabilities, we selected grit42 as our strategic software partner.
For identification of phenotypes of mutants, we use the high-throughput phenotypic microarrays from OmniLog®. The Growth Curves app from grit42 offers a nice and interactive way to analyse this data as well as making our analysis workflow 15 times faster!